BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Week in Review: Tigermed, a Hangzhou CRO, Plans IPO


8/6/2012 9:51:41 AM

by Richard Daverman, PhD

August 4, 2012 -- Tigermed Consulting, the clinical-stage CRO headquartered in Hangzhou, will stage an IPO on the ChiNext exchange, with pricing expected August 6; Covidien officially opened its China medical device R&D facility in Shanghai’s Caohejing Hi-Tech Park; Luqa Pharma of Hong Kong in-licensed China rights to a scar treatment from Stratpharma, a Swiss company; Kinex Pharma, a New York-state startup developing cancer drugs, received an investment from Dr. Manson Fok of Hong Kong; Barclays Bank raised its rating for the China healthcare space, moving to Positive on the sector; and Roche will hire an additional 1,000 people in China over the next year, as the company’s China revenues continue to climb. More details….

Stock Symbols: (NYSE: COV) (VX: ROG)



Read at ChinaBio Today

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->